Clinical Trials Logo

Clinical Trial Summary

Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.


Clinical Trial Description

Primary objective:

Characterize altered molecular pathways in lung cancer in patients with IPF versus lung cancer in non-IPF patients.

Secondary objectives:

Identify specific therapeutic targets Describe a cohort of lung cancers on IPF (clinical / radiological and pathological data) To study the relationship between neoplastic / preneoplastic lesions and pulmonary parenchyma reshaped by fibrosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03486262
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Enrolling by invitation
Phase
Start date February 1, 2018
Completion date February 2020